Delia O’Hara is an award-winning writer and journalist, a former longtime features reporter for the Chicago Sun-Times. Specialties include science, health care, profiles, education, history, culture and the arts for magazines and websites. She is presently a member of the National Association of Science Writers and the Association of Health Care Journalists. She is also a published short story writer.
Delia O’Hara
From this contributor
Beyond the bench: A conversation with Konstantinos Zarbalis
Konstantinos “Kostas” Zarbalis talks about the upside of unexpected experimental results, and why he eats just one meal per day.
Beyond the bench: A conversation with Konstantinos Zarbalis
By
Delia O’Hara
10 February 2022 | 6 min read
Beyond the bench: A conversation with Kristin Sohl
When pediatrician Kristin Sohl isn’t building programs to improve care for and research about autistic people, you can find her reading psychological thrillers or playing Pokémon Go.
Beyond the bench: A conversation with Kristin Sohl
By
Delia O’Hara
13 January 2022 | 6 min read
Beyond the bench: A conversation with Andrew Whitehouse
Andrew Whitehouse talks about his conservation efforts in the Australian Outback, what it’s like to be an identical twin and why he leaves work promptly at 5 p.m.
Beyond the bench: A conversation with Andrew Whitehouse
By
Delia O’Hara
24 November 2021 | 7 min read
Beyond the bench: A conversation with Ethan Scott
Ethan Scott packs his lab with math, physics and computer science experts to decode sensory brain networks in zebrafish models of autism.
Beyond the bench: A conversation with Ethan Scott
By
Delia O’Hara
13 September 2021 | 9 min read
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
By
Natalia Mesa
3 June 2026 | 11 min read
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
By
Paul Middlebrooks
3 June 2026 | 1 min read
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
By
Calli McMurray
2 June 2026 | 5 min read